Table 1.
Summary of the patients’ characteristics
| Parameter | No. (%) |
|---|---|
| Sex | |
| Male | 34 (73.9) |
| Female | 12 (26.1) |
| Age, median (range, yr) | 46 (27-85) |
| Time from primary diagnosis to SBRT treatment, median (range, yr) | 1.7 (0.5-11.6) |
| WHO performance status | |
| 0 | 28 (60.9) |
| 1 | 11 (23.9) |
| 2 | 7 (15.2) |
| Metastatic status | |
| Solitary | 20 (43.5) |
| Oligometastatic | 26 (56.5) |
| Primitive tumor site | |
| Lung | 30 (65.2) |
| Colorectal | 7 (15.2) |
| Other | 9 (19.6) |
| Primary tumor histology | |
| Adenocarcinoma | 29 (63.0) |
| NSCLC | 5 (10.9) |
| Other | 12 (26.1) |
| Laterality | |
| Right | 30 (65.2) |
| Left | 16 (35.8) |
SBRT, stereotactic body radiation therapy; WHO, World Health Organization; NSCLC, non-small-cell lung carcinoma.